Skip to main content

Table 1 Sociodemographic characteristics

From: Idiographic analyses of motivation and related processes in participants with schizophrenia following a therapeutic intervention for negative symptoms

Individual

2i-1

2i-2

2i-4

Age

29

34

39

Gender

Female

Male

Female

Diagnosis

SZ

SZ

SZ

Illness duration (years)

10

10

7

Education (year)

10

12

14

Living Conditions

With partner

Supervised housing

With family

Work

/

/

/

Switch (number of sessions + booster session)

12 + 1

15 + 1

10 + 0

Medication / dose / CPZeq

Aripiprazole / 2.5 mg/day / 50 mg

Aripiprazole / 200 mg/month / 142.86 mg

Olanzapine / 350 mg/3 months /

277.47 mg

  1. CPZeq Chlorpromazine equivalents (mg/day) [26]